NSCLC STAGE IIIB

Clinical trials for NSCLC STAGE IIIB explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE IIIB trials appear

Sign up with your email to follow new studies for NSCLC STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Lung cancer drug trial halted early: what we know

Disease control Terminated

This early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a powerful chemotherapy directly to cancer cells…

Matched conditions: NSCLC STAGE IIIB

Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC

NSCLC STAGE IIIB

Get alerted when new NSCLC STAGE IIIB trials appear

Lung cancer drug trial halted early: what we know